Delivery Order SPE2DB22D9304-SPE2DB24FSSZ9

Award Date 8/7/24
Potential Completion Date 8/28/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA), a defense agency of the U.S. government. The contract has a ceiling value of $1,726.89 and is a firm fixed-price delivery order with no set-aside designation. The prime contractor is DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This award is part of a larger indefinite delivery contract (IDC) held by DMS...
This federal contract award is for the delivery of Mirena 52 mg Systems to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a delivery order with a firm fixed-price pricing type and has a ceiling value of $29,600.00. The contract has an ultimate completion date of March 12, 2024, and was awarded on February 20, 2024. The award is...
This federal contract award is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $59,200.00 and an ultimate completion date of October 18, 2024. DMS Pharmaceutical Group Inc. specializes in providing a wide range of pharmaceutical...
This federal contract award is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA), which is a Defense agency. The contract was awarded to the prime contractor, DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $14,208.00 and an ultimate completion date of August 15, 2024. This award is part of a larger indefinite delivery...
This federal contract award is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $7,104.00 and an ultimate completion date of October 18, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with...
The federal contract award is for the delivery of MIRENA 52 MG SYSTEMS to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This is a firm fixed-price delivery order contract valued at $7,104.00, with a period of performance through May 20, 2024. The contract is not associated with a set-aside program. DMS Pharmaceutical Group holds a larger...
This federal contract award is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense (DoD). The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $35,520.00 and a period of performance through September 20, 2024. The contract is not associated with a...
This federal contract award is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA), a defense agency. The contract has a ceiling value of $12,178.80 and was awarded on August 31, 2021 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order and is not associated with a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award...
This federal contract award is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The prime contractor is DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $17,851.68 and a completion date of February 12, 2025. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of 4,565,404,982 units of the Mirena 52 mg intrauterine system to the Defense Logistics Agency (DLA). The contract, with a ceiling value of $4,736.00, is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up...
  • SPE2DB22D9304
    Indefinite Delivery Contract
  • SPE2DB22D9304-SPE2DB24FSSZ9
    Delivery Order

This federal contract award is for the delivery of Mirena 52 mg systems to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The total ceiling value of the contract is $11,840.00, and it is structured as a firm fixed-price delivery order with no set-aside designation. The contract has an ultimate completion date of August 28, 2024. DMS Pharmaceutical Group Inc. holds a significant indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at up to $499,999,999, which runs through December 31, 2025. This IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide.

Generated 11/6/24, 9:26 AM